Vitamin D Testing Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	140 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224236

Best Price Guarantee
Price	from $4,850
Length	140 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224236

Vitamin D Testing Market

Growth Factors of Vitamin D Testing Market

The global vitamin D testing market size was valued at USD 652.2 million in 2023 and is projected to grow from USD 682.2 million in 2024 to USD 1021.3 million by 2032, exhibiting a CAGR of 5.2% during the forecast period of 2024-2032.

The COVID-19 pandemic brought on a temporary decline in diet D testing due to healthcare device disruptions. However, developing cognizance of diet D's function in immunity has pushed renewed hobby, boosting market restoration, impeding the vitamin D testing market growth.

The Vitamin D Testing Market is driven by the rising incidence of diet D deficiency, extended cognizance of its health advantages, improved checking-out technologies, and the developing aged population. The call for home testing kits and the hyperlink between nutrition D ranges and chronic diseases contribute to the marketplace boom.

Home trying kits for vitamin D have become increasingly popular, empowering people to take control of their health and display their diet D degrees. These kits provide a handy and inexpensive choice for clients to get admission to vitamin D trying out without the need for a physician's appointment or laboratory visit, expanding the vitamin D testing market share globally. This direct-to-client (DTC) version gives more accessibility and versatility, allowing individuals to tune their vitamin D status without problems and make knowledgeable decisions about their fitness.

Comprehensive Analysis of Vitamin D Testing Market

The Vitamin D Testing Market is segmented by product, application, and consumer. The 25-hydroxy vitamin D check leads the marketplace, identified because the gold general for assessing nutrition D tiers, while the 1.25-dihydroxy nutrition D checking out section is expected to develop the fastest due to its use in diagnosing sarcoidosis and renal disorder. In applications, scientific testing dominates, pushed via accelerated recognition and advanced testing kits, with studies checking out additionally seeing a large boom from investments in innovative kits. Standalone clinical laboratories are desired for stop-users' superior abilities, with hospitals and clinics predicted to develop because of improved infrastructure and study activities.

The Europe region led the vitamin D testing market by benefitting a size of USD 231.8 million in 2023 due to its full-size contribution, this vicinity held the most significant share within the global vitamin D testing market.

The leading players in the vitamin D testing market play a crucial role in shaping its growth and establishing industry standards. Key companies such as F. Hoffmann-La Roche Ltd. (Switzerland), DiaSorin S.p.A. (Italy), Abbott (U.S.), bioMérieux SA (France), Siemens Healthcare GmbH (Germany), Beckman Coulter, Inc. (U.S.), Quidel Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), and RECIPE Chemicals + Instruments GmbH (Germany) contribute to a competitive landscape that drives innovation and advancements in the market.

In May 2020, Abbott announced that ID NOW will be had in the U.S., offering a speedy point-of-care test that grants effects in minutes rather than the usual days or weeks.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 5.2% from 2024-2032

Unit Value (USD million)

Segmentation

By Product

25-Hydroxy Vitamin D Testing
1,25-Dihydroxy Vitamin D Testing
24,25-Dihydroxy Vitamin D Testing

By Application

Clinical Testing
Research Testing

By End-User

Standalone Clinical Laboratories
Hospitals & Clinics
Others

By Geography

North America (By Product, By Application, By End-User, and By Country)
U.S.
Canada
Europe (By Product, By Application, By End-User, and By Country/Sub-region)
U.K.
Germany
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Product, By Application, By End-User, and By Country/Sub-region)
Japan
China
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Product, By Application, By End-User, and By Country/Sub-region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Product, By Application, By End-User, and By Country/Sub-region)
South Africa
GCC Countries
Rest of Middle East & Africa

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Prevalence of Vitamin D Deficiency - For Key Countries, 2022/2023; 4.2. Vitamin D Testing Volumes - For Key Countries/Regions, 2023 and 2032; 4.3. Technological Evolution in Vitamin D Testing; 4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships; 4.5. Key Growth Indicators of Vitamin D Testing Market; 4.6. Impact of COVID-19 on the Market
5. Global Vitamin D Testing Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Product; 5.1.1. 25-Hydroxy Vitamin D Testing; 5.1.2. 1,25-Dihydroxy Vitamin D Testing; 5.1.3. 24,25-Dihydroxy Vitamin D Testing; 5.2. Market Analysis, Insights and Forecast – By Application; 5.2.1. Clinical Testing; 5.2.2. Research Testing; 5.3. Market Analysis, Insights and Forecast – By End-User; 5.3.1. Standalone Clinical Laboratories; 5.3.2. Hospitals & Clinics; 5.3.3. Others; 5.4. Market Analysis, Insights and Forecast – By Geography; 5.4.1. North America; 5.4.2. Europe; 5.4.3. Asia Pacific; 5.4.4. Latin America; 5.4.5. Middle East & Africa
6. North America Vitamin D Testing Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Product; 6.1.1. 25-Hydroxy Vitamin D Testing; 6.1.2. 1,25-Dihydroxy Vitamin D Testing; 6.1.3. 24,25-Dihydroxyvitamin D Testing; 6.2. Market Analysis, Insights and Forecast – By Application; 6.2.1. Clinical Testing; 6.2.2. Research Testing; 6.3. Market Analysis, Insights and Forecast – By End-User; 6.3.1. Standalone Clinical Laboratories; 6.3.2. Hospitals & Clinics; 6.3.3. Others; 6.4. Market Analysis, Insights and Forecast – By Country; 6.4.1. U.S.; 6.4.2. Canada
7. Europe Vitamin D Testing Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Product; 7.1.1. 25-Hydroxy Vitamin D Testing; 7.1.2. 1,25-Dihydroxy Vitamin D Testing; 7.1.3. 24,25-Dihydroxyvitamin D Testing; 7.2. Market Analysis, Insights and Forecast – By Application; 7.2.1. Clinical Testing; 7.2.2. Research Testing; 7.3. Market Analysis, Insights and Forecast – By End-User; 7.3.1. Standalone Clinical Laboratories; 7.3.2. Hospitals & Clinics; 7.3.3. Others; 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 7.4.1. U.K.; 7.4.2. Germany; 7.4.3. France; 7.4.4. Italy; 7.4.5. Spain; 7.4.6. Scandinavia; 7.4.7. Rest of Europe
8. Asia Pacific Vitamin D Testing Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Product; 8.1.1. 25-Hydroxy Vitamin D Testing; 8.1.2. 1,25-Dihydroxy Vitamin D Testing; 8.1.3. 24,25-Dihydroxyvitamin D Testing; 8.2. Market Analysis, Insights and Forecast – By Application; 8.2.1. Clinical Testing; 8.2.2. Research Testing; 8.3. Market Analysis, Insights and Forecast – By End-User; 8.3.1. Standalone Clinical Laboratories; 8.3.2. Hospitals & Clinics; 8.3.3. Others; 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 8.4.1. Japan; 8.4.2. China; 8.4.3. India; 8.4.4. Australia; 8.4.5. Southeast Asia; 8.4.6. Rest of Asia Pacific
9. Latin America Vitamin D Testing Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Product; 9.1.1. 25-Hydroxy Vitamin D Testing; 9.1.2. 1,25-Dihydroxy Vitamin D Testing; 9.1.3. 24,25-Dihydroxyvitamin D Testing; 9.2. Market Analysis, Insights and Forecast – By Application; 9.2.1. Clinical Testing; 9.2.2. Research Testing; 9.3. Market Analysis, Insights and Forecast – By End-User; 9.3.1. Standalone Clinical Laboratories; 9.3.2. Hospitals & Clinics; 9.3.3. Others; 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 9.4.1. Brazil; 9.4.2. Mexico; 9.4.3. Rest of Latin America
10. Middle East & Africa Vitamin D Testing Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Product; 10.1.1. 25-Hydroxy Vitamin D Testing; 10.1.2. 1,25-Dihydroxy Vitamin D Testing; 10.1.3. 24,25-Dihydroxyvitamin D Testing; 10.2. Market Analysis, Insights and Forecast – By Application; 10.2.1. Clinical Testing; 10.2.2. Research Testing; 10.3. Market Analysis, Insights and Forecast – By End-User; 10.3.1. Standalone Clinical Laboratories; 10.3.2. Hospitals & Clinics; 10.3.3. Others; 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 10.4.1. South Africa; 10.4.2. GCC Countries; 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. F. Hoffmann-La Roche Ltd.; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. DiaSorin S.p.A.; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. Abbott; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. bioMérieux SA; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. Siemens Healthcare GmbH; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. Beckman Coulter, Inc.; 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. Quidel Corporation; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. Thermo Fisher Scientific; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 11.2.9. Recipe Chemical + Instruments GmbH; 11.2.9.1. Overview; 11.2.9.2. Products & Services; 11.2.9.3. SWOT Analysis; 11.2.9.4. Recent Developments; 11.2.9.5. Strategies; 11.2.9.6. Financials (Based on Availability); 12.